SKYLA belongs to the LITE-ON Corporation Group (TW STOCK: 2301), is dedicated to developing innovative medical devices focused on analyzers with versatile & multiplexing platforms for POCT of IVD.
Skyla has been marketing to 54 countries globally and established more than 60 channels since 2011. With advanced R&D technology, skyla’s products have achieved major certifications. We strive to continuously create trustworthy products to meet worldwide healthcare demands.